252 related articles for article (PubMed ID: 8501169)
21. Pulsatile growth hormone release in Turner's syndrome and short normal children.
Ghizzoni L; Lamborghini A; Ziveri M; Volta C; Panza C; Balestrazzi P; Bernasconi S
Acta Endocrinol (Copenh); 1990 Sep; 123(3):291-7. PubMed ID: 2239077
[TBL] [Abstract][Full Text] [Related]
22. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
[TBL] [Abstract][Full Text] [Related]
24. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
Reiter JC; Craen M; Van Vliet G
Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
[TBL] [Abstract][Full Text] [Related]
25. Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation.
Zadik Z; Landau H; Chen M; Altman Y; Lieberman E
J Clin Endocrinol Metab; 1992 Aug; 75(2):412-6. PubMed ID: 1386373
[TBL] [Abstract][Full Text] [Related]
26. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
[TBL] [Abstract][Full Text] [Related]
27. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
28. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
29. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes.
Hochberg Z; Aviram M; Rubin D; Pollack S
Eur J Clin Invest; 1997 Jul; 27(7):543-7. PubMed ID: 9263738
[TBL] [Abstract][Full Text] [Related]
30. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
31. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
32. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
Reiter EO; Blethen SL; Baptista J; Price L
J Clin Endocrinol Metab; 2001 May; 86(5):1936-41. PubMed ID: 11344188
[TBL] [Abstract][Full Text] [Related]
33. IGF-I resistance and Turner's syndrome.
Lebl J; Průhová S; Zapletalová J; Pechová M
J Pediatr Endocrinol Metab; 2001 Jan; 14(1):37-41. PubMed ID: 11220703
[TBL] [Abstract][Full Text] [Related]
34. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone therapy in Turner's syndrome: one versus two daily injections.
De Schepper J; Craen M; Massa G; Heinrichs C; Maes M; Du Caju M; Rausin L; Bourguignon JP
J Clin Endocrinol Metab; 1994 Aug; 79(2):489-94. PubMed ID: 8045968
[TBL] [Abstract][Full Text] [Related]
36. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
37. Effects of growth hormone therapy on the developmental changes of follicle stimulating hormone and insulin-like growth factor-I serum concentrations in Turner's syndrome.
Bourguignon JP; Gérard A; Deby-Dupont G; Franchimont P
Clin Endocrinol (Oxf); 1993 Jul; 39(1):85-9. PubMed ID: 8348710
[TBL] [Abstract][Full Text] [Related]
38. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.
Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G
J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone secretion in pubertal age patients with Turner's syndrome.
Lanes R; Brito S; Suniaga M; Moncada G; Borges M
J Clin Endocrinol Metab; 1990 Sep; 71(3):770-2. PubMed ID: 2394779
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
